Colgate-Palmolive (CL) | Financial Analysis & Statements
Colgate-Palmolive Co. Large-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
5.2B
Gross Profit
3.1B
60.15%
Operating Income
1.0B
19.48%
Net Income
-5.0M
-0.10%
EPS (Diluted)
$-0.05
Balance Sheet Metrics
Total Assets
16.3B
Total Liabilities
16.0B
Shareholders Equity
365.0M
Debt to Equity
43.74
Cash Flow Metrics
Operating Cash Flow
351.0M
Free Cash Flow
1.3B
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Colgate-Palmolive Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 20.4B | 20.1B | 19.5B | 18.0B | 17.4B |
| Cost of Goods Sold | 8.1B | 7.9B | 8.1B | 7.7B | 7.0B |
| Gross Profit | 12.3B | 12.2B | 11.3B | 10.2B | 10.4B |
| Gross Margin % | 60.1% | 60.5% | 58.2% | 57.0% | 59.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 7.9B | 7.7B | 7.2B | 6.6B | 6.4B |
| Other Operating Expenses | - | - | - | 65.0M | 4.0M |
| Total Operating Expenses | 7.9B | 7.7B | 7.2B | 6.6B | 6.4B |
| Operating Income | 4.2B | 4.3B | 4.1B | 3.6B | 3.9B |
| Operating Margin % | 20.8% | 21.5% | 21.0% | 20.1% | 22.4% |
| Non-Operating Items | |||||
| Interest Income | 75.0M | 67.0M | 55.0M | 14.0M | 17.0M |
| Interest Expense | 267.0M | 292.0M | 287.0M | 167.0M | 117.0M |
| Other Non-Operating Income | -982.0M | -149.0M | -461.0M | -804.0M | -723.0M |
| Pre-tax Income | 3.1B | 4.0B | 3.4B | 2.7B | 3.1B |
| Income Tax | 798.0M | 907.0M | 937.0M | 693.0M | 749.0M |
| Effective Tax Rate % | 26.1% | 22.9% | 27.6% | 26.1% | 24.3% |
| Net Income | 2.3B | 3.0B | 2.5B | 2.0B | 2.3B |
| Net Margin % | 11.1% | 15.2% | 12.6% | 10.9% | 13.4% |
| Key Metrics | |||||
| EBITDA | 4.9B | 4.9B | 4.3B | 4.0B | 4.4B |
| EPS (Basic) | $2.64 | $3.53 | $2.78 | $2.13 | $2.56 |
| EPS (Diluted) | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 |
| Basic Shares Outstanding | 808700000 | 819100000 | 827400000 | 836400000 | 845000000 |
| Diluted Shares Outstanding | 808700000 | 819100000 | 827400000 | 836400000 | 845000000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Colgate-Palmolive Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 1.3B | 1.1B | 966.0M | 775.0M | 832.0M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 1.7B | 1.5B | 1.6B | 1.5B | 1.3B |
| Inventory | 2.0B | 2.0B | 1.9B | 2.1B | 1.7B |
| Other Current Assets | 714.0M | 713.0M | 793.0M | 760.0M | 576.0M |
| Total Current Assets | 5.7B | 5.3B | 5.3B | 5.1B | 4.4B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.5B | 1.6B | 1.6B | 1.6B | 1.6B |
| Goodwill | 7.8B | 8.3B | 8.7B | 8.6B | 9.0B |
| Intangible Assets | 1.5B | 1.8B | 1.9B | 1.9B | 2.5B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.3B | 1.3B | 1.2B | 1.0B | 1.2B |
| Total Non-Current Assets | 10.6B | 10.7B | 11.1B | 10.6B | 10.6B |
| Total Assets | 16.3B | 16.0B | 16.4B | 15.7B | 15.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 2.1B | 1.8B | 1.7B | 1.6B | 1.5B |
| Short-term Debt | 1.2B | 767.0M | 425.0M | 133.0M | 188.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 22.0M | 23.0M | 26.0M | 15.0M | 6.0M |
| Total Current Liabilities | 6.9B | 5.8B | 4.7B | 4.0B | 4.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 7.3B | 7.7B | 8.6B | 9.1B | 7.6B |
| Deferred Tax Liabilities | 181.0M | 343.0M | 361.0M | 383.0M | 395.0M |
| Other Non-Current Liabilities | 362.0M | 320.0M | 305.0M | 271.0M | 254.0M |
| Total Non-Current Liabilities | 9.1B | 9.7B | 10.7B | 10.9B | 10.0B |
| Total Liabilities | 16.0B | 15.5B | 15.4B | 14.9B | 14.1B |
| Equity | |||||
| Common Stock | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B |
| Retained Earnings | 26.6B | 26.1B | 25.3B | 24.6B | 24.4B |
| Treasury Stock | 28.4B | 27.4B | 26.0B | 25.1B | 24.1B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 365.0M | 544.0M | 957.0M | 806.0M | 971.0M |
| Key Metrics | |||||
| Total Debt | 8.6B | 8.5B | 9.1B | 9.3B | 7.8B |
| Working Capital | -1.1B | -442.0M | 538.0M | 1.1B | 346.0M |
Balance Sheet Composition
Colgate-Palmolive Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.3B | 3.0B | 2.5B | 2.0B | 2.3B |
| Depreciation & Amortization | 630.0M | 605.0M | 567.0M | 545.0M | 556.0M |
| Stock-Based Compensation | 155.0M | 135.0M | 122.0M | 125.0M | 135.0M |
| Working Capital Changes | 33.0M | -172.0M | 146.0M | -611.0M | -211.0M |
| Operating Cash Flow | 3.0B | 3.6B | 3.4B | 2.0B | 2.7B |
| Investing Activities | |||||
| Capital Expenditures | - | 0 | 0 | 47.0M | 0 |
| Acquisitions | -293.0M | 0 | 0 | -809.0M | 0 |
| Investment Purchases | -698.0M | -574.0M | -506.0M | -470.0M | -141.0M |
| Investment Sales | 752.0M | 564.0M | 502.0M | 322.0M | 141.0M |
| Investing Cash Flow | -253.0M | 27.0M | -37.0M | -905.0M | -25.0M |
| Financing Activities | |||||
| Share Repurchases | -1.2B | -1.7B | -1.1B | -1.3B | -1.3B |
| Dividends Paid | -1.8B | -1.8B | -1.7B | -1.7B | -1.7B |
| Debt Issuance | 1.2B | 2.0M | 1.5B | 1.5B | 699.0M |
| Debt Repayment | -655.0M | -503.0M | -903.0M | -406.0M | -703.0M |
| Financing Cash Flow | -3.4B | -4.0B | -3.2B | -1.4B | -3.2B |
| Free Cash Flow | 3.6B | 3.5B | 3.0B | 1.9B | 2.8B |
| Net Change in Cash | -582.0M | -409.0M | 226.0M | -278.0M | -558.0M |
Cash Flow Trend
Colgate-Palmolive Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
31.83
Forward P/E
20.55
Price to Book
1,249.55
Price to Sales
3.30
PEG Ratio
-0.30
Profitability Ratios
Profit Margin
10.46%
Operating Margin
20.38%
Return on Equity
497.47%
Return on Assets
16.36%
Financial Health
Current Ratio
0.83
Debt to Equity
2,343.56
Beta
0.33
Per Share Data
EPS (TTM)
$2.63
Book Value per Share
$0.07
Revenue per Share
$25.20
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CL | 67.9B | 31.83 | 1,249.55 | 497.47% | 10.46% | 2,343.56 |
| Procter & Gamble | 340.5B | 21.55 | 6.48 | 31.56% | 19.30% | 68.72 |
| Kimberly-Clark | 47.7B | 19.60 | 43.35 | 207.06% | 12.48% | 595.10 |
| Kenvue | 33.6B | 22.78 | 3.08 | 14.39% | 9.72% | 80.58 |
| Estee Lauder | 28.1B | 124.05 | 6.94 | -4.34% | -1.21% | 232.95 |
| Church & Dwight | 22.5B | 31.32 | 5.59 | 17.62% | 11.88% | 59.52 |
Financial data is updated regularly. All figures are in the company's reporting currency.






